EffCaMgCit

DRUG3 trials

Sponsors

University of Texas Southwestern Medical Center

Conditions

CKD Stage 5HypomagnesemiaOsteoporosis

Phase 2

Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V

Active, not recruitingNCT03565913

University of Texas Southwestern Medical CenterCKD Stage 5

Start: 2017-01-22End: 2026-12-18Updated: 2026-06-03

Phase 3

Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate

TerminatedNCT03812380

University of Texas Southwestern Medical CenterHypomagnesemia, Osteoporosis

Start: 2019-01-01End: 2021-08-11Updated: 2022-08-17

EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

WithdrawnNCT05998863

University of Texas Southwestern Medical CenterHypomagnesemia, Osteoporosis

Start: 2024-04-19End: 2026-06-25Updated: 2026-06-30